Nac Al (Acetylcysteine)

Acetylcysteine breaks disulfide bonds within mucus glycoproteins, reducing the viscosity of sputum and making it easier to cough up. Additionally, it replenishes intracellular glutathione, supporting antioxidant defenses and reducing oxidative stress in the respiratory tract.

The appropriate dose of Nac Al is determined by the prescribing healthcare professional based on the patient’s condition, age, and renal or hepatic function. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for acetylcysteine in pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against possible risks before prescribing. Women who are pregnant or breastfeeding should discuss use with their physician.

To request Nac Al, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Acetylcysteine, the active ingredient in Nac Al, is a thiol‑containing mucolytic that directly cleaves mucus disulfide bonds, whereas other agents such as carbocisteine or ambroxol act mainly by stimulating serous secretion. Acetylcysteine also offers antioxidant benefits, which can be an advantage in oxidative lung injury.

Nac Al should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Nac Al is taken orally, typically as a tablet or liquid formulation, according to the prescriber’s directions. It should be swallowed with water and may be taken with or without food, unless otherwise advised by a healthcare professional.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm in susceptible individuals, and significant liver enzyme elevations. Any signs of severe allergy or respiratory distress require immediate medical attention.

Patients with known hypersensitivity to acetylcysteine or any excipients in the product should avoid Nac Al. Caution is also advised for individuals with severe asthma, uncontrolled hepatic disease, or those taking medications that may interact significantly, such as nitroglycerin or anticoagulants.